Ranitidine Hydrochloride Capsules

Ranitidine.

This product is a capsule, and its contents are off-white or light yellow powder.

1. Oral administration: 150 mg (1 tablet at a time), twice a day, or 300 mg (2 tablets at a time), once before bedtime. 2. Maintenance treatment: Oral administration: 150 mg (1 tablet at a time), once every night. 3. For patients with severe renal disease, the half-life of ranitidine is prolonged, and the dose should be reduced to 75 mg (half a tablet at a time), twice a day. 4. For the treatment of Zollinger-Ellison syndrome, a large amount of 600-1200 mg per day (4-8 tablets per day) is recommended.

Not yet clear.

It is not suitable for children under 8 years old. It is not suitable for pregnant or lactating women.

Precautions for children: Children under 8 years old are prohibited. Precautions for pregnancy and lactation: Precautions for pregnant and lactating women. Precautions for the elderly: The liver and kidney functions of the elderly are reduced. To ensure the safety of medication, the dosage should be adjusted.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

seal.

0.15g*36s

24 months

Chongqing Tianzhi Pharmaceutical Co., Ltd.

• Founded in:

  2016-10-31

• Address:

  Building 1, No. 10 Dongpu Avenue, Zhaojia Street, Kaizhou District, Chongqing

• Tax NO.:

  91500234MA5U87EPX1

• Registered Funds:

  356.5497 million yuan

• Website:

  Log in to view

• Email:

  Log in to view